210 related articles for article (PubMed ID: 26159576)
41. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
[TBL] [Abstract][Full Text] [Related]
42. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
Bharatham N; Bharatham K; Lee KW
J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives.
Leung E; Pilkington LI; van Rensburg M; Jeon CY; Song M; Arabshahi HJ; De Zoysa GH; Sarojini V; Denny WA; Reynisson J; Barker D
Bioorg Med Chem; 2016 Mar; 24(5):1142-54. PubMed ID: 26853836
[TBL] [Abstract][Full Text] [Related]
44. Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues.
Jarvest RL; Armstrong SA; Berge JM; Brown P; Elder JS; Brown MJ; Copley RC; Forrest AK; Hamprecht DW; O'Hanlon PJ; Mitchell DJ; Rittenhouse S; Witty DR
Bioorg Med Chem Lett; 2004 Aug; 14(15):3937-41. PubMed ID: 15225702
[TBL] [Abstract][Full Text] [Related]
45. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety.
Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P
Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents.
Liu T; Sun C; Xing X; Jing L; Tan R; Luo Y; Huang W; Song H; Li Z; Zhao Y
Bioorg Med Chem Lett; 2012 May; 22(9):3122-5. PubMed ID: 22483608
[TBL] [Abstract][Full Text] [Related]
48. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies.
Petrović MM; Roschger C; Chaudary S; Zierer A; Mladenović M; Jakovljević K; Marković V; Botta B; Joksović MD
Bioorg Chem; 2020 Dec; 105():104373. PubMed ID: 33074120
[TBL] [Abstract][Full Text] [Related]
49. Design and synthesis of quinolinones as methionyl-tRNA synthetase inhibitors.
Farhanullah ; Kim SY; Yoon EJ; Choi EC; Kim S; Kang T; Samrin F; Puri S; Lee J
Bioorg Med Chem; 2006 Nov; 14(21):7154-9. PubMed ID: 16854585
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and anticancer activity of aminodihydroquinoline analogs: identification of novel proapoptotic agents.
Lee E; Han S; Jin GH; Lee HJ; Kim WY; Ryu JH; Jeon R
Bioorg Med Chem Lett; 2013 Jul; 23(13):3976-8. PubMed ID: 23684895
[TBL] [Abstract][Full Text] [Related]
52. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and antiproliferative activity of unsaturated quinoline derivatives.
Montgomery GJ; McKeown P; McGown AT; Robins DJ
Anticancer Drug Des; 2000 Jun; 15(3):171-81. PubMed ID: 11049085
[TBL] [Abstract][Full Text] [Related]
54. Deoxyribosyl analogues of methionyl and isoleucyl sulfamate adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases.
Kim SE; Kim SY; Kim S; Kang T; Lee J
Bioorg Med Chem Lett; 2005 Jul; 15(14):3389-93. PubMed ID: 15951176
[TBL] [Abstract][Full Text] [Related]
55. Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
Makawana JA; Sangani CB; Lin L; Zhu HL
Bioorg Med Chem Lett; 2014 Apr; 24(7):1734-6. PubMed ID: 24630412
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
Sukhorukov AY; Nirvanappa AC; Swamy J; Ioffe SL; Nanjunda Swamy S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2014 Aug; 24(15):3618-21. PubMed ID: 24909082
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors.
Lv X; Ying H; Ma X; Qiu N; Wu P; Yang B; Hu Y
Eur J Med Chem; 2015 Jun; 99():36-50. PubMed ID: 26046312
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
59. Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors.
Kalirajan R; Kulshrestha V; Sankar S; Jubie S
Eur J Med Chem; 2012 Oct; 56():217-24. PubMed ID: 22982526
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.
Xi J; Xu S; Zhang L; Bi X; Ren Y; Liu YC; Gu Y; Xu Y; Lan F; Zha X
Bioorg Chem; 2018 Aug; 78():7-16. PubMed ID: 29524666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]